More than 800 million individuals have diabetes globally, doubling in the last three decades according to research recently ...

An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk ...

This immune response results in chronic high blood sugar for diabetes patients, which can lead to other serious health ...

Type 1 diabetes, once known as juvenile or insulin-dependent diabetes, is a chronic health condition. In people with this ...

On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering ...

Corxel Pharmaceuticals (CORXEL), a leading biotech company committed to bringing innovative science and medicines to underserved patients with cardiometabolic diseases around the world, today ...

In a surprising twist that challenges conventional wisdom about body weight and health, new research suggests that having a ...

In 2024, the projected revenue in the Anti-Diabetes Drugs market in China is estimated to reach US$9.46bn. Furthermore, it is expected that this revenue will experience an annual growth rate (CAGR ...

Adult non–insulin requiring diabetes includes latent autoimmune diabetes of adults (LADA), distinguished from type 2 diabetes by the presence of islet autoantibodies. LADA China determined the ...

A new round of China's bulk buy program for drugs will include 385 products from 234 companies in an effort to further reduce ...

Moderate- to vigorous-intensity physical activity (MVPA) during pregnancy is inversely associated with preterm birth in women ...